Endoscopic therapy of superficial bladder cancer in high-risk patients: Holmium laser versus transurethral resection.

Giovanni B. Muraro, Riccardo Grifoni, Liana Spazzafumo

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Many lasers are widely used in urological surgery for several applications. Their use to treat the superficial bladder cancer (SBC) is safe and minimally invasive. The Holmium:YAG (Ho:YAG) laser represents the pinnacle of laser technology in Urology. The authors carried out this study on safety, efficacy, complication rates, postoperative catheterization time, and hospital stay of high-risk patients who underwent Ho:YAG vs. transurethral resection (TUR). Two groups of high-risk patients with SBC and comorbidities underwent either Ho:YAG or TUR. Different clinical aspects of the tumours and recurrences were considered. No significant difference between the two groups was noted regarding number, progression of grade and stage and place and time of recurrences. In the Ho:YAG patients, perioperative complications occurred at a lower percent than in the TUR group. Also, in 54% of patients, the catheter was removed within 24 hours; 76% had a postoperative hospital stay of 24 to 48 hours. In the TUR patients: 4% had the catheter removed within 24 hours and 6% left the hospital within 24 to 48 hours. In SBC treatment, Ho:YAG and TUR were equally as effective; the Ho:YAG laser was associated with shorter catheterization time and hospital stay. These Ho:YAG features could be advantageous from a psychological standpoint, particularly for elderly, high-risk patients and in terms of cost:benefit ratios.

Original languageEnglish
Pages (from-to)222-226
Number of pages5
JournalSurgical technology international
Volume14
Publication statusPublished - 2005

Fingerprint

Holmium
Solid-State Lasers
Urinary Bladder Neoplasms
Length of Stay
Catheterization
Lasers
Therapeutics
Catheters
Recurrence
Urology
Cost-Benefit Analysis
Comorbidity
Psychology
Technology
Safety
Neoplasms

Cite this

Endoscopic therapy of superficial bladder cancer in high-risk patients : Holmium laser versus transurethral resection. / Muraro, Giovanni B.; Grifoni, Riccardo; Spazzafumo, Liana.

In: Surgical technology international, Vol. 14, 2005, p. 222-226.

Research output: Contribution to journalArticle

@article{78764c60f65e44268cae4fbcdb9ce26f,
title = "Endoscopic therapy of superficial bladder cancer in high-risk patients: Holmium laser versus transurethral resection.",
abstract = "Many lasers are widely used in urological surgery for several applications. Their use to treat the superficial bladder cancer (SBC) is safe and minimally invasive. The Holmium:YAG (Ho:YAG) laser represents the pinnacle of laser technology in Urology. The authors carried out this study on safety, efficacy, complication rates, postoperative catheterization time, and hospital stay of high-risk patients who underwent Ho:YAG vs. transurethral resection (TUR). Two groups of high-risk patients with SBC and comorbidities underwent either Ho:YAG or TUR. Different clinical aspects of the tumours and recurrences were considered. No significant difference between the two groups was noted regarding number, progression of grade and stage and place and time of recurrences. In the Ho:YAG patients, perioperative complications occurred at a lower percent than in the TUR group. Also, in 54{\%} of patients, the catheter was removed within 24 hours; 76{\%} had a postoperative hospital stay of 24 to 48 hours. In the TUR patients: 4{\%} had the catheter removed within 24 hours and 6{\%} left the hospital within 24 to 48 hours. In SBC treatment, Ho:YAG and TUR were equally as effective; the Ho:YAG laser was associated with shorter catheterization time and hospital stay. These Ho:YAG features could be advantageous from a psychological standpoint, particularly for elderly, high-risk patients and in terms of cost:benefit ratios.",
author = "Muraro, {Giovanni B.} and Riccardo Grifoni and Liana Spazzafumo",
year = "2005",
language = "English",
volume = "14",
pages = "222--226",
journal = "Surgical technology international",
issn = "1090-3941",
publisher = "Universal Medical Press",

}

TY - JOUR

T1 - Endoscopic therapy of superficial bladder cancer in high-risk patients

T2 - Holmium laser versus transurethral resection.

AU - Muraro, Giovanni B.

AU - Grifoni, Riccardo

AU - Spazzafumo, Liana

PY - 2005

Y1 - 2005

N2 - Many lasers are widely used in urological surgery for several applications. Their use to treat the superficial bladder cancer (SBC) is safe and minimally invasive. The Holmium:YAG (Ho:YAG) laser represents the pinnacle of laser technology in Urology. The authors carried out this study on safety, efficacy, complication rates, postoperative catheterization time, and hospital stay of high-risk patients who underwent Ho:YAG vs. transurethral resection (TUR). Two groups of high-risk patients with SBC and comorbidities underwent either Ho:YAG or TUR. Different clinical aspects of the tumours and recurrences were considered. No significant difference between the two groups was noted regarding number, progression of grade and stage and place and time of recurrences. In the Ho:YAG patients, perioperative complications occurred at a lower percent than in the TUR group. Also, in 54% of patients, the catheter was removed within 24 hours; 76% had a postoperative hospital stay of 24 to 48 hours. In the TUR patients: 4% had the catheter removed within 24 hours and 6% left the hospital within 24 to 48 hours. In SBC treatment, Ho:YAG and TUR were equally as effective; the Ho:YAG laser was associated with shorter catheterization time and hospital stay. These Ho:YAG features could be advantageous from a psychological standpoint, particularly for elderly, high-risk patients and in terms of cost:benefit ratios.

AB - Many lasers are widely used in urological surgery for several applications. Their use to treat the superficial bladder cancer (SBC) is safe and minimally invasive. The Holmium:YAG (Ho:YAG) laser represents the pinnacle of laser technology in Urology. The authors carried out this study on safety, efficacy, complication rates, postoperative catheterization time, and hospital stay of high-risk patients who underwent Ho:YAG vs. transurethral resection (TUR). Two groups of high-risk patients with SBC and comorbidities underwent either Ho:YAG or TUR. Different clinical aspects of the tumours and recurrences were considered. No significant difference between the two groups was noted regarding number, progression of grade and stage and place and time of recurrences. In the Ho:YAG patients, perioperative complications occurred at a lower percent than in the TUR group. Also, in 54% of patients, the catheter was removed within 24 hours; 76% had a postoperative hospital stay of 24 to 48 hours. In the TUR patients: 4% had the catheter removed within 24 hours and 6% left the hospital within 24 to 48 hours. In SBC treatment, Ho:YAG and TUR were equally as effective; the Ho:YAG laser was associated with shorter catheterization time and hospital stay. These Ho:YAG features could be advantageous from a psychological standpoint, particularly for elderly, high-risk patients and in terms of cost:benefit ratios.

UR - http://www.scopus.com/inward/record.url?scp=33745047146&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33745047146&partnerID=8YFLogxK

M3 - Article

C2 - 16525976

AN - SCOPUS:33745047146

VL - 14

SP - 222

EP - 226

JO - Surgical technology international

JF - Surgical technology international

SN - 1090-3941

ER -